[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [United Therapeutics, Corp.](/topic/united-therapeutics-corp) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "UBS reiterated $INSM at a Buy rating and a $XXX price target. $LQDA $UTHR UBS said: We see more upside to the Brinsupri story in NCFB following our KOL checks and survey results (n=29) with pulmonologists that manage 2.8K NCFB patients with confirmed diagnosis by CT scan. We are doing a KOL call on Brinsupri launch on 10/21 2pm ET. While our survey accounts for less than X% of NCFB patients with X exacerbations surveyed physicians noted XXX prescriptions written through September 2025. With the caveat that our physician checks indicate it can take 2-4 weeks for patients to initiate therapy" [X Link](https://x.com/Quantumup1/status/1980348113907830862) [@Quantumup1](/creator/x/Quantumup1) 2025-10-20T18:59Z 3849 followers, 2845 engagements "$LQDA Looks like Judge Andrews calendar is free until the 29th of Oct. I expect we get a decision this week. Will be busy with the following catalysts. Oct 21st - Chest ASCENT Wk16 data Oct 28th - L606 R&D Day Oct 29th - $UTHR Earnings Nov 12th (est) - $LQDA Earnings" [X Link](https://x.com/mbamcnulty/status/1979815445772542402) [@mbamcnulty](/creator/x/mbamcnulty) 2025-10-19T07:42Z XX followers, 3428 engagements "UBSthe PT on $INSM to $XXX from $XXX and reiterated at Buy after adding in additional Brinsupri indications to its model. $LQDA $UTHR UBS said that it expects rapid uptake of Brinsupri in non-cystic fibrosis bronchiectasis (NCFB) patientsINSM is well-positioned to execute on the launch as the sales force was deployed approximately XX months prior to launch engaging with physicians on disease education. UBS additionally said: We are raising our PT to $XXX (from $140) as we layer in additional Brinsupri indications in our model. INSM stock is up +136% YTD but we see more upside from here as -" [X Link](https://x.com/Quantumup1/status/1978096926642888783) [@Quantumup1](/creator/x/Quantumup1) 2025-10-14T13:53Z 3849 followers, 6315 engagements "Some thoughts from ChatGPT on the XXX patent lawsuit between $LQDA & $UTHR" [X Link](https://x.com/paperhands91/status/1974529316890534169) [@paperhands91](/creator/x/paperhands91) 2025-10-04T17:37Z XXX followers, 3228 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"UBS reiterated $INSM at a Buy rating and a $XXX price target. $LQDA $UTHR UBS said: We see more upside to the Brinsupri story in NCFB following our KOL checks and survey results (n=29) with pulmonologists that manage 2.8K NCFB patients with confirmed diagnosis by CT scan. We are doing a KOL call on Brinsupri launch on 10/21 2pm ET. While our survey accounts for less than X% of NCFB patients with X exacerbations surveyed physicians noted XXX prescriptions written through September 2025. With the caveat that our physician checks indicate it can take 2-4 weeks for patients to initiate therapy"
X Link @Quantumup1 2025-10-20T18:59Z 3849 followers, 2845 engagements
"$LQDA Looks like Judge Andrews calendar is free until the 29th of Oct. I expect we get a decision this week. Will be busy with the following catalysts. Oct 21st - Chest ASCENT Wk16 data Oct 28th - L606 R&D Day Oct 29th - $UTHR Earnings Nov 12th (est) - $LQDA Earnings"
X Link @mbamcnulty 2025-10-19T07:42Z XX followers, 3428 engagements
"UBSthe PT on $INSM to $XXX from $XXX and reiterated at Buy after adding in additional Brinsupri indications to its model. $LQDA $UTHR UBS said that it expects rapid uptake of Brinsupri in non-cystic fibrosis bronchiectasis (NCFB) patientsINSM is well-positioned to execute on the launch as the sales force was deployed approximately XX months prior to launch engaging with physicians on disease education. UBS additionally said: We are raising our PT to $XXX (from $140) as we layer in additional Brinsupri indications in our model. INSM stock is up +136% YTD but we see more upside from here as -"
X Link @Quantumup1 2025-10-14T13:53Z 3849 followers, 6315 engagements
"Some thoughts from ChatGPT on the XXX patent lawsuit between $LQDA & $UTHR"
X Link @paperhands91 2025-10-04T17:37Z XXX followers, 3228 engagements
/topic/united-therapeutics-corp/posts